<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01195558</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00005099</org_study_id>
    <nct_id>NCT01195558</nct_id>
  </id_info>
  <brief_title>Patient Registry of Blind Subjects With Sleep-related Problems</brief_title>
  <official_title>Development of a Patient Registry of Blind Subjects With Sleep-related Problems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanda Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanda Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-24-hour sleep-wake disorder (Non-24) is a condition experienced primarily by totally
      blind individuals that results in abnormal night sleep patterns and chronic daytime
      sleepiness. This is a research protocol to develop a patient registry of subjects who may
      suffer from Non-24 and who are blind. Subjects participate in the study through a phone
      survey. This registry will be used to better understand, sleep related problems in blind
      individuals, including the investigation of a potential treatment, recruitment for future
      clinical studies, and to provide a forum for raising awareness about Non-24. The survey
      consists of questions regarding the degree of vision impairment and sleep problems that the
      subjects may be experiencing.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">April 2030</completion_date>
  <primary_completion_date type="Anticipated">April 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of blind participants</measure>
    <time_frame>ongoing</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep/wake disruptions</measure>
    <time_frame>ongoing</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Sleep-wake Disorder in Blind Individuals</condition>
  <arm_group>
    <arm_group_label>Blind with sleep problems</arm_group_label>
    <description>Blind individuals with no light perception and with sleep-related problems who may suffer from Non-24</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection on blindness and sleep problems</intervention_name>
    <description>Data related to degree of vision impairment and sleep problems is collected through a phone or web survey</description>
    <arm_group_label>Blind with sleep problems</arm_group_label>
    <other_name>Data Collection</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        General population of blind individuals
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects or legal guardians must be at least 18 years of age to participate in the
             telephone survey. Parents or legal guardians may represent children from 0 through 17
             years who meet the following criteria.

          2. Subjects must be blind.

          3. Subjects must have some self-described problem with sleep or daytime sleepiness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vanda Pharmaceuticals</last_name>
    <phone>(202) 734-3400</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Vanda Pharmaceuticals</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanda Pharmaceuticals</last_name>
      <phone>202-734-3400</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 2, 2010</study_first_submitted>
  <study_first_submitted_qc>September 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2010</study_first_posted>
  <last_update_submitted>June 22, 2020</last_update_submitted>
  <last_update_submitted_qc>June 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non-24</keyword>
  <keyword>N24HSWD</keyword>
  <keyword>Blindness</keyword>
  <keyword>Sleep</keyword>
  <keyword>Wake</keyword>
  <keyword>Circadian Rhythm</keyword>
  <keyword>Nap</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Wake Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

